Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03629236 · ClinicalTrials.gov registry record · NA
Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers
A NA study of Venous Leg Ulcer, sponsored by Osiris Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT03629236 is a NA study of Venous Leg Ulcer that has completed, run by Osiris Therapeutics. The registered enrollment target is 200 participants, below the 239-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (16% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03629236, a NA study of Venous Leg Ulcer, has completed, sponsored by Osiris Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
A Multicenter, Prospective, Randomized, Open-Label Study with a Crossover Extension Option to Evaluate the Safety and Efficacy of GrafixPL for the Treatment of Chronic VLUs
Conditions Studied
Interventions
- OTHER Control
- OTHER GrafixPL
Study Locations (2)
Florida
- Integral Clinical Trial Solutions - Doral
Massachusetts
- SSH - Weymouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-06-27 |
| Est. Completion | 2021-06-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03629236
The ClinicalTrials.gov registry entry for NCT03629236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 239-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (16% lower). The listed sponsor is Osiris Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT03629236 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03629236 about?
NCT03629236 is a clinical study titled "Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers". A Multicenter, Prospective, Randomized, Open-Label Study with a Crossover Extension Option to Evaluate the Safety and Efficacy of GrafixPL for the Treatment of Chronic VLUs
What is the current status of trial NCT03629236?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2018-06-27. Estimated completion is 2021-06-24.
What conditions does trial NCT03629236 study?
This clinical trial studies the following conditions: Venous Leg Ulcer.
What interventions are being tested in trial NCT03629236?
The interventions under investigation include: Control (OTHER), GrafixPL (OTHER).
Who is sponsoring clinical trial NCT03629236?
This trial is sponsored by Osiris Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03629236 being conducted?
This trial has 2 study locations across Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.